Sylvia Cheung | CFO, Treasurer & Secretary |
Cheryl Blanchard | Interim CEO & Director |
James Loerop | EVP, Business Development & Strategic Planning |
Joseph Munda | First Analysis |
Michael Petusky | Barrington Research Associates |
James Sidoti | Sidoti & Company |
Good evening, ladies and gentlemen, and welcome to Anika Therapeutics Fourth Quarter and Full Year 2019 Earnings Conference Call. [Operator Instructions].
I will now turn the call over to Sylvia Cheung, Chief Financial Officer. Please proceed.
Thank you, Lide.